Melanoma Marker (MART-1 + Tyrosinase + gp100) (DT101+ BC199 + T311 + HMB45), CF488A conjugate, 0.1mg/mL
Melanoma Marker (MART-1 + Tyrosinase + gp100) (DT101+ BC199 + T311 + HMB45), CF488A conjugate, 0.1mg/mL thumbnail 1
GTR00931885

Melanoma Marker (MART-1 + Tyrosinase + gp100) (DT101+ BC199 + T311 + HMB45), CF488A conjugate, 0.1mg/mL

antibody-app-enzyme

Supplier: Biotium
£264.92($350.36)
Size: 1x 100 µL

Description

This antibody cocktail recognizes three melanoma-specific proteins, which include MART-1, Tyrosinase and gp100. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Tyrosinase is one of the targets for cytotoxic T-cell recognition in melanoma patients. Function of gp100 is not known but it is reported to be a useful marker for melanocytes and melanomas. This cocktail of three markers is designed for extremely sensitive labeling of formalin-fixed, paraffin-embedded melanomas and other tumors showing melanocytic differentiation.

Specifications

CAS Number
9007-83-4
Synonyms
Melanoma antigen recognized by T-cells 1 (MART-1), MLAN-A; PMEL17
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Source
Animal
Host
Mouse
Shipping
RT (ND)
Storage
Stable at room temperature or 37°C (98°F) for 7 days.